
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About
Mirion Technologies Inc (MIR)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/14/2025: MIR (5-star) is a STRONG-BUY. BUY since 49 days. Profits (28.11%). Updated daily EoD!
1 Year Target Price $19.6
1 Year Target Price $19.6
3 | Strong Buy |
2 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 76.96% | Avg. Invested days 35 | Today’s Advisory Strong Buy |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.70B USD | Price to earnings Ratio - | 1Y Target Price 19.6 |
Price to earnings Ratio - | 1Y Target Price 19.6 | ||
Volume (30-day avg) 5 | Beta 0.81 | 52 Weeks Range 9.11 - 22.21 | Updated Date 07/13/2025 |
52 Weeks Range 9.11 - 22.21 | Updated Date 07/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.05 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -1.15% | Operating Margin (TTM) 4.31% |
Management Effectiveness
Return on Assets (TTM) 0.99% | Return on Equity (TTM) -0.63% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 5231927301 | Price to Sales(TTM) 5.41 |
Enterprise Value 5231927301 | Price to Sales(TTM) 5.41 | ||
Enterprise Value to Revenue 6.01 | Enterprise Value to EBITDA 27.22 | Shares Outstanding 223996000 | Shares Floating 191949850 |
Shares Outstanding 223996000 | Shares Floating 191949850 | ||
Percent Insiders 4.45 | Percent Institutions 85.66 |
Upturn AI SWOT
Mirion Technologies Inc
Company Overview
History and Background
Mirion Technologies, Inc. was founded in 2006 as a spin-off from Thermo Electron Corporation's dosimetry and radiation monitoring businesses. It has grown through acquisitions and organic growth to become a leading provider of radiation detection, measurement, analysis, and monitoring solutions.
Core Business Areas
- Detection and Measurement: Offers a comprehensive range of radiation detection and measurement instruments, including handheld devices, portable systems, and laboratory equipment.
- Sensing Systems: Provides radiation monitoring systems for nuclear power plants, research facilities, and other industrial applications.
- Dosimetry Services: Offers radiation dosimetry services to monitor occupational radiation exposure for workers in various industries.
- Medical: Provides medical radiation equipment such as brachytherapy and oncology quality assurance solutions.
Leadership and Structure
The leadership team includes the CEO and other key executives. The organizational structure is departmental, with divisions focusing on different product lines and geographic regions.
Top Products and Market Share
Key Offerings
- AccuRad: A handheld radiation detection device used by first responders and homeland security personnel. Market share is estimated at 20% within its category. Competitors include FLIR Systems (now Teledyne FLIR) and Canberra Industries.
- RDS-31: A survey meter used in nuclear power plants, industrial facilities, and environmental monitoring. Market share is estimated at 15% in its category. Competitors include Thermo Fisher Scientific and Ludlum Measurements.
- Instadose+: A personal radiation dosimeter used for monitoring occupational radiation exposure. Competitors include Landauer and Radiation Detection Company (RDC).
- Aquila: Brachytherapy planning and quality assurance solutions for medical radiation oncology. Competitors include Varian Medical Systems and Elekta.
Market Dynamics
Industry Overview
The radiation detection and monitoring industry is driven by factors such as increasing concerns about nuclear safety, growing demand for medical imaging, and stringent regulatory requirements. The industry is competitive, with several major players and numerous smaller companies.
Positioning
Mirion Technologies Inc. is positioned as a leading provider of radiation detection and measurement solutions, with a strong reputation for quality and innovation. It has a broad product portfolio and a global customer base.
Total Addressable Market (TAM)
The TAM for radiation detection and monitoring equipment and services is estimated to be around $10 billion. Mirion Technologies is well positioned with a strong product portfolio and is expected to capture a significant share.
Upturn SWOT Analysis
Strengths
- Broad product portfolio
- Global customer base
- Strong brand reputation
- Technological expertise
- Compliance with regulatory standards
Weaknesses
- Dependence on nuclear power industry
- Exposure to economic cycles
- Competition from larger companies
- Integration risk from acquisitions
Opportunities
- Growing demand for radiation detection in emerging markets
- Increasing use of radiation in medical applications
- Development of new radiation detection technologies
- Expansion into related markets such as nuclear waste management
Threats
- Decline in nuclear power generation
- Regulatory changes
- Technological obsolescence
- Economic recession
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- TDY
- FLIR
- Thermo Fisher Scientific
Competitive Landscape
Mirion possesses a broad product portfolio, and a good reputation. Competitors may have better penetration in certain niche markets, or benefit from greater brand recognition, or scale.
Major Acquisitions
Gems Radition Monitoring Systems
- Year: 2016
- Acquisition Price (USD millions): 85
- Strategic Rationale: Expansion of nuclear power plant monitoring capabilities
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be evaluated by analyzing revenue, earnings, and market share over the past few years. This will help to identify trends and growth drivers.
Future Projections: Future growth projections can be obtained from analyst reports and company guidance. These estimates will provide insights into expected revenue, earnings, and market share growth.
Recent Initiatives: Recent initiatives include strategic acquisitions, new product launches, and expansion into new markets. These actions can drive future growth and enhance competitiveness.
Summary
Mirion Technologies is a leading player in the radiation detection and monitoring industry. Its broad product portfolio and global presence provide a strong foundation. However, reliance on the nuclear power sector, potential disruptions due to new technologies or economic downturns, and integration risks from acquisitions are issues to look out for. Strategic diversification and innovation will be essential to maintaining its market position.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Analyst Reports
- Industry Publications
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a financial advisor. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mirion Technologies Inc
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2020-08-20 | Founder, Medical Group President, CEO & Chairman Mr. Thomas D. Logan | ||
Sector Industrials | Industry Specialty Industrial Machinery | Full time employees 2800 | Website https://www.mirion.com |
Full time employees 2800 | Website https://www.mirion.com |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.